SkinBioTherapeutics (SBTX) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 May 2017 07:00 AM
RNS
Extension of Research Contract
05 Apr 2017 07:00 AM
RNS
First day of dealings - to trade under SBTX ticker

SkinBioTherapeutics is a life science company that develops technologies to improve health by harnessing the human microbiome.

SkinBioTherapeutics is based in Newcastle upon Tyne, United Kingdom.

SkinBioTherapeutics is listed in London under the ticker SBTX.

SBTX share price listed at 16p in 2017.

UK 100

Latest directors dealings